The evolving role of genetic tests in reproductive medicine

F Cariati, V D'Argenio, R Tomaiuolo - Journal of translational medicine, 2019 - Springer
Infertility is considered a major public health issue, and approximately 1 out of 6 people
worldwide suffer from infertility during their reproductive lifespans. Thanks to technological …

Applications of next generation sequencing in the screening and diagnosis of thalassemia: A mini-review

SA Suhaimi, IN Zulkipli, H Ghani… - Frontiers in …, 2022 - frontiersin.org
Thalassemias are a group of inherited blood disorders that affects 5–7% of the world
population. Comprehensive screening strategies are essential for the management and …

Non-invasive prenatal testing for autosomal recessive disorders: A new promising approach

Y Alyafee, A Al Tuwaijri, M Umair, M Alharbi… - Frontiers in …, 2022 - frontiersin.org
Background: In pregnant women at risk of autosomal recessive (AR) disorders, prenatal
diagnosis of AR disorders primarily involves invasive procedures, such as chorionic villus …

Optimized droplet digital PCR assay on cell-free DNA samples for non-invasive prenatal diagnosis: application to beta-thalassemia

CG Constantinou, E Karitzi, S Byrou… - Clinical …, 2022 - academic.oup.com
Background Thalassemias are inherited blood disorders and by far one of the most common
monogenic diseases globally. Beta-thalassemia has a particularly high prevalence in …

Non‐invasive prenatal testing for fetal inheritance of maternal β‐thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study

L Xiong, AN Barrett, R Hua, SSY Ho… - … Journal of Obstetrics …, 2018 - Wiley Online Library
Objective To evaluate whether targeted sequencing and relative mutation dosage can be
used to diagnose correctly inheritance of maternal β‐thalassaemia mutations in cell‐free …

Thalassemia in the laboratory: pearls, pitfalls, and promises

G Aliyeva, C Asadov, T Mammadova… - Clinical Chemistry and …, 2018 - degruyter.com
Thalassemia is one of the most common hereditary disorders of the developing world, and it
is associated with severe anemia and transfusion dependence. The global health burden of …

Noninvasive prenatal diagnosis of beta-thalassemia disease by using digital PCR analysis of cell-free fetal DNA in maternal plasma

P Charoenkwan, K Traisrisilp, S Sirichotiyakul… - Fetal Diagnosis and …, 2023 - karger.com
Introduction: Prenatal diagnosis of thalassemia disease was usually based on invasive
technique. Noninvasive diagnosis using cell-free fetal DNA (cff-DNA) was described with …

[HTML][HTML] The current applications of cell-free fetal DNA in prenatal diagnosis of single-gene diseases: A review

MM Mortazavipour, S Shahbazi - International Journal of …, 2022 - ncbi.nlm.nih.gov
Prenatal diagnosis of hereditary diseases has substantially altered the way medical
geneticists are helping families affected by genetic disorders. However, the risk of …

Noninvasive Prenatal Genetic Screening of Cell-Free Fetal DNA for Early Prediction of β-Thalassemia Using Fiber Optic Nanogold-Linked Sorbent Assay

LT Ngo, P Chaudhari, WK Wang, YT Tseng, PL Kuo… - ACS …, 2024 - ACS Publications
β-Thalassemia is a prevalent type of severe inherited chronic anemia, primarily identified in
developing countries. The identification of single nucleotide polymorphisms (SNPs) plays a …

Current and future molecular approaches in the diagnosis of cystic fibrosis

A Bergougnoux, M Taulan-Cadars… - Expert review of …, 2018 - Taylor & Francis
ABSTRACT Introduction: Cystic Fibrosis is among the first diseases to have general
population genetic screening tests and one of the most common indications of prenatal and …